PD-L1 Levels Fail to Predict ALK Inhibitor Benefit in Lung Cancer Cohort
A 129-patient Japanese multicenter study found that tumor PD-L1 expression did not predict the effectiveness of ALK inhibitor therapy in ...
A 129-patient Japanese multicenter study found that tumor PD-L1 expression did not predict the effectiveness of ALK inhibitor therapy in ...
A retrospective study of 682 patients in Tianjin found 12.17 percent developed liver injury on immune checkpoint inhibitor therapy, with ...
A new review highlights the JAK/STAT signalling pathway as a potential link between SARS-CoV-2 infection, post-COVID autoimmune phenomena and the ...
Gladstone Institutes physician-scientists Melanie Ott and Alex Marson have been elected to the National Academy of Medicine in recognition of ...
Phase 3 DeLLphi-305 results show that adding tarlatamab to durvalumab as first-line maintenance therapy extended median overall survival by more ...
A new review argues that natural killer cells in colorectal cancer liver metastasis form a heterogeneous, microenvironment-shaped spectrum of states ...
A case report in Oncotarget describes how an international molecular tumor board weighed treatment options for a 52-year-old woman with ...
A study in Medical Oncology reports that the E3 ubiquitin ligase RNF152 is low in clear cell renal cell carcinoma, ...
A new review details how metabolites produced by Fusobacterium nucleatum drive periodontal inflammation, reprogram colorectal tumor metabolism and immunity, and ...
A new study shows that cooperative signals from macrophages, stellate cells and cancer cells switch on the tumor-promoting protein CHI3L1 ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine